 |
|
Effect of Prednisone on Growth and Bone Mineral Content in Childhood Glomerular Disease
Russell W. Chesney, MD;
Richard B. Mazess, PhD;
Philip Rose;
Diane K. Jax, RT
Am J Dis Child. 1978;132(8):768-772.
Abstract
| |
• Children with acquired glomerular disease were divided into two groups: Group 1 patients received short-term daily or long-term alternate-day prednisone (up to 2.7 mg/kg/48 hr); group 2 patients received no corticosteroids. Height, bone mineral content (BMC), and bone density were evaluated in the two groups and compared to those of 800 sex- and age-matched controls; BMC and bone density were assessed by the photon absorption technique.
Significant demineralization was present in 18 of 25 prednisone-treated and none of the 17 nonprednisone-treated patients (P <.001). Group 1 patients were 5.3 ± 0.7% shorter than controls, while group 2 patients were only 1.9 ±.8% shorter (P <.02). Height velocity was 2.6 ± 0.8 cm/yr in group 1 and 5.1 ± 0.8 cm/yr in group 2 patients (P <.05). When prednisone therapy was discontinued, six patients had an increase in height and BMC toward normal values.
This study suggests that BMC and height velocity are correlated. Both appear to be influenced by alternate-day prednisone therapy rather than by glomerular disease per se.
(Am J Dis Child 132:768-772, 1978)
Author Affiliations
From the Departments of Pediatrics and Radiology, University of Wisconsin Center for Health Sciences, and the Pediatric Renal Disease Laboratory, Children's Hospital of Wisconsin, Madison.
Footnotes
Read in part before the American Society of Pediatric Nephrology Workshop on Growth in Childhood Renal Disease, Carmel, Calif, April 1977.
Reprint requests to Department of Pediatrics, University of Wisconsin Hospitals, 300 University Ave, Madison, WI 53706 (Dr Chesney).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Increased Osteoblastic Activity and Expression of Receptor Activator of NF-{kappa}B Ligand in Nonuremic Nephrotic Syndrome
Freundlich et al.
J. Am. Soc. Nephrol. 2005;16:2198-2204.
ABSTRACT
| FULL TEXT
Delayed Pubertal Growth Spurt and Normal Adult Height Attainment in Boys Receiving Long-term Alternate-day Prednisone Therapy
Polito et al.
CLIN PEDIATR 1999;38:279-285.
ABSTRACT
Bone Mineral Content in Nephrotic Children on Long-Term, Alternate-Day Prednisone Therapy
Polito et al.
CLIN PEDIATR 1995;34:234-236.
ABSTRACT
Long-term, Small Dose Prednisone Therapy in Frequently Relapsing Nephrotic Syndrome of Childhood: Effect on Remission, Statural Growth, Obesity, and Infection Rate
Elzouki and Jaiswal
CLIN PEDIATR 1988;27:387-392.
ABSTRACT
The Noninvasive Determination of Bone Mineral Content by Photon Absorptiometry
CHESNEY and SHORE
Arch Pediatr Adolesc Med 1982;136:578-580.
ABSTRACT
Supranormal 25-Hydroxyvitamin D and Subnormal 1,25-Dihydroxyvitamin D: Their Role in X-linked Hypophosphatemic Rickets
Chesney et al.
Arch Pediatr Adolesc Med 1980;134:140-143.
ABSTRACT
Demineralization in Cystic Fibrosis: Detected by Direct Photon Absorptiometry
Mischler et al.
Arch Pediatr Adolesc Med 1979;133:632-635.
ABSTRACT
|
